Table 2.

Reported cases of Ovarian Carcinoids

Serial number	Case report/case series	Patients (n)	Author (year)	Primary/metastatic	UL/BL	Presence of teratomatous elements in background	Evidence of distant metastasis	Predominant HPE	IHC
1	Case series	35	Robboy et al (1974)19	Metastatic	80% BL	0	92%	Not specified	Not done
2	Case series	48	Robboy et al (1975)20	Primary	81% UL	76%	0%	Insular	Not done
3	Case report	1	Finn et al (1991)21	Metastatic	BL	Absent	Present	Insular	Neuron-specific enolase, chromogranin, serotonin+
4	Case report	1	Ikeda et al (1991)22	Metastatic	BL	Absent	Present	Goblet cell carcinoid	Chromogranin A, serotonin+
5	Case series	17	Davis et al (1996)23	Primary	100% UL	63%	35%	Insular	Not done
6	Case series	329	Soga et al (2000)24	Primary	–	57%		Insular+trabecular	–
7	Case series	17	Strosber et al (2007)25	Metastatic	88% BL	Absent	76%	Insular	Not done
8	Case series	26	Rabban et al (2009)26	16 primary/10 metastatic	100% UL in primary 70% BL in metastatic	62% in primary Absent in metastatic	6% in primary 60% in metastatic	Insular in both primary and metastatic	CDX2+ in 37.2% in primary and 100% in metastatic
9	Case report	1	Chen et al (2010)27	Primary	UL	Present	Absent	Strumal carcinoid	Chromogranin, synaptophysin+, CK7, CK20−
10	Case report	1	Kanayama et al (2012)28	Primary	UL	Present	No	Insular	Grimelius+, chromogranin A+, synaptophysin+
11	Case report	1	Hinshaw et al (2012)29	Primary	UL	Present	Absent	Strumal carcinoid	Synaptophysin, TTF-1
12	Case series	56	Desouki et al (2013)30	46 primary/10 metastatic	Details not available	35% in primary Absent in metastatic	Details not available	Insular	CDX2+ in 90% metastatic carcinoid, <1

BL, bilateral; IHC, immunohistochemistry; TTF-1, transcription termination factor 1; UL, unilateral.